RLM van der Ham, RA Dehnavi, JFP Berbée, … - Diabetes Care, 2009 - Am Diabetes Assoc OBJECTIVE—To determine whether, in accordance with observations in mouse
models, high concentrations of the lipoprotein lipase inhibitors apolipoprotein
(Apo) CI and ApoCIII are associated with increased triglyceride ... Cited by 1 - Related articles - All 3 versions
- ►nih.gov EF Schippers, JFP Berbée, IM van … - Intensive care medicine, 2008 - Springer EF Schippers (u) · IM van Disseldorp · JT van Dissel Leiden University Medical
Center, Department of Infectious Diseases, C5-P42, PO Box 9600, 2300 RC Leiden,
The Netherlands e-mail: EFSchippers@lumc.nl Tel.: +31-71-5262613 Fax: ... Cited by 4 - Related articles - All 7 versions
- ►bdwm.net [PDF] IJ Goldberg, RH Eckel, NA Abumrad - The Journal of Lipid Research, 2009 - ASBMB Cells obtain FAs either from LPL-catalyzed hydrolysis of lipoprotein
triglyceride or from unesterified FFAs associated with albumin. LPL also
influences uptake of esterified lipids such as cholesteryl and retinyl ... Cited by 5 - Related articles - All 5 versions
- ►jlr.org M Westerterp, JFP Berbee, DJM Delsing, MC … - The Journal of Lipid Research, 2007 - ASBMB Mice that overexpress human apolipoprotein CI (apoC-I) homozygously (APOC1 +/+
mice) are protected against obesity and show cutaneous abnormalities. Although
these effects can result from our previous observation that apoC-I inhibits ... Cited by 5 - Related articles - All 4 versions
JM Ramis, B Bibiloni, J Moreiro, JM García- … - The Journal of Nutritional Biochemistry, 2005 - Elsevier The development of metabolic complications of obesity has been associated with
the existence of depot-specific differences in the biochemical properties of
adipocytes. The aim of this study was to investigate, in severely obese men ... Cited by 6 - Related articles - All 7 versions
R Alizadeh Dehnavi, A de Roos, TJ Rabelink, … - Atherosclerosis, 2008 - Elsevier BACKGROUND: Visceral obesity (VO) is associated with an increased risk of
cardiovascular disease. Elevated C-reactive protein (CRP) levels are associated
with VO and cardiovascular disease. After exploring the relation between ... Cited by 6 - Related articles - All 34 versions
MS Wroblewski, JT Wilson-Grady, MB Martinez … - FEBS JOURNAL, 2006 - interscience.wiley.com A survey of plasma proteins in approximately 1300 individuals by MALDI-TOF MS
resulted in identification of a structural polymorphism of apolipoprotein C1
(ApoC1) that was found only in persons of American Indian or Mexican ... Cited by 6 - Related articles - BL Direct - All 4 versions
J De Graaf, MJV Hoffer, PMJ Stuyt, RR Frants … - Biochemical and Biophysical Research …, 2000 - Elsevier Apolipoprotein CII (ApoCII) deficiency is a relatively rare cause of the
chylomicronemia syndrome, a disorder characterized by severe fasting
hypertriglyceridemia and massive accumulation of chylomicrons in plasma. ... Cited by 8 - Related articles - BL Direct - All 6 versions
C Blackburn, B Guan, J Brown, C Cullis, SM … - Bioorganic & Medicinal Chemistry Letters, 2006 - Elsevier Blocking the absorption of fats (triglycerides) by administration of an
anti-absorptive agent is of interest for the treatment of obesity. 1 Ingested
dietary triglycerides are hydrolyzed by gastric and pancreatic lipases, and ... Cited by 7 - Related articles - All 5 versions
- ►shouxi.net J Shearer, PT Fueger, DP Bracy, DH … - Diabetes, 2005 - Am Diabetes Assoc The aim of this study was to determine the contribution of heart-type fatty
acid–binding protein (H-FABP) to glucose and long-chain fatty acid (LCFA)
utilization in dietary-induced insulin resistance. We tested the hypothesis ... Cited by 9 - Related articles - BL Direct - All 5 versions
